Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing.

Bioact Mater · 2022 · PMC8636679 · PMID 34901560

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The SIS/LXW7-DS-SILY/EPCs group showed a trend toward more rapid re-epithelialization as compared to the SIS/EPCs group, as determined by shorter residual wound length ( Fig. 8 C–D panel b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.